These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8570763)

  • 1. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder.
    Nelson EC; Sheline YI; Bardgett ME; Jackson JL; Csernansky JG
    Psychiatry Res; 1995 Sep; 58(2):117-25. PubMed ID: 8570763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients.
    Marazziti D; Rossi A; Gemignani A; Giannaccini G; Pfanner C; Milanfranchi A; Presta S; Lucacchini A; Cassano GB
    Neuropsychobiology; 1996; 34(4):184-7. PubMed ID: 9121618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients.
    Bastani B; Arora RC; Meltzer HY
    Biol Psychiatry; 1991 Jul; 30(2):131-9. PubMed ID: 1655071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive behaviour and platelet 3H-paroxetine binding in schizophrenia.
    Maguire K; Cheung P; Crowley K; Norman T; Schweitzer I; Burrows G
    Schizophr Res; 1997 Jan; 23(1):61-7. PubMed ID: 9050129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased platelet imipramine binding in Tourette syndrome children with obsessive-compulsive disorder.
    Weizman A; Mandel A; Barber Y; Weitz R; Cohen A; Mester R; Rehavi M
    Biol Psychiatry; 1992 Apr; 31(7):705-11. PubMed ID: 1318082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome.
    Sallee FR; Richman H; Beach K; Sethuraman G; Nesbitt L
    J Am Acad Child Adolesc Psychiatry; 1996 Dec; 35(12):1647-56. PubMed ID: 8973072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet 3H-imipramine binding sites in obsessive-compulsive behavior.
    Kim SW; Dysken MW; Pandey GN; Davis JM
    Biol Psychiatry; 1991 Sep; 30(5):467-74. PubMed ID: 1657222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls.
    Black DW; Kelly M; Myers C; Noyes R
    Biol Psychiatry; 1990 Feb; 27(3):319-27. PubMed ID: 2154266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder.
    Delorme R; Betancur C; Callebert J; Chabane N; Laplanche JL; Mouren-Simeoni MC; Launay JM; Leboyer M
    Neuropsychopharmacology; 2005 Aug; 30(8):1539-47. PubMed ID: 15886722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?
    Geller DA; Biederman J; Stewart SE; Mullin B; Farrell C; Wagner KD; Emslie G; Carpenter D
    J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S19-29. PubMed ID: 12880497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.
    Weizman A; Carmi M; Hermesh H; Shahar A; Apter A; Tyano S; Rehavi M
    Am J Psychiatry; 1986 Mar; 143(3):335-9. PubMed ID: 3006522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine.
    Brody AL; Saxena S; Fairbanks LA; Alborzian S; Demaree HA; Maidment KM; Baxter LR
    J Clin Psychiatry; 2000 May; 61(5):349-55. PubMed ID: 10847309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet imipramine binding and serotonin uptake in obsessive-compulsive patients.
    Vitiello B; Shimon H; Behar D; Stoff D; Bridger WH; Friedman E
    Acta Psychiatr Scand; 1991 Jul; 84(1):29-32. PubMed ID: 1927563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.
    Delorme R; Chabane N; Callebert J; Falissard B; Mouren-Siméoni MC; Rouillon F; Launay JM; Leboyer M
    J Clin Psychopharmacol; 2004 Feb; 24(1):18-23. PubMed ID: 14709942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet paroxetine binding in post-traumatic stress disorder.
    Maguire K; Norman T; Burrows G; Hopwood M; Morris P
    Psychiatry Res; 1998 Jan; 77(1):1-7. PubMed ID: 10710169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet [3H]paroxetine binding in patients with OCD-related disorders.
    Marazziti D; Dell'Osso L; Presta S; Pfanner C; Rossi A; Masala I; Baroni S; Giannaccini G; Lucacchini A; Cassano GB
    Psychiatry Res; 1999 Dec; 89(3):223-8. PubMed ID: 10708268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.
    Rosel P; Menchón JM; Vallejo J; Arranz B; Navarro MA; Lirón F; Alvarez P
    J Affect Disord; 1997 Jun; 44(1):79-85. PubMed ID: 9186805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features.
    Fichtner CG; O'Connor FL; Yeoh HC; Arora RC; Crayton JW
    Life Sci; 1995; 57(2):PL37-44. PubMed ID: 7603291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naturalistic course of obsessive compulsive disorder and comorbid depression. Longitudinal results of a prospective follow-up study of 74 actively treated patients.
    Zitterl W; Demal U; Aigner M; Lenz G; Urban C; Zapotoczky HG; Zitterl-Eglseer K
    Psychopathology; 2000; 33(2):75-80. PubMed ID: 10705250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients.
    Marazziti D; Conti L; Pfanner C; Presta S; Rossi A; Gemignani A; Dell'Osso L; Cassano GB
    Neuropsychobiology; 2001; 43(3):117-22. PubMed ID: 11287787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.